1. Home
  2. RDY vs RKT Comparison

RDY vs RKT Comparison

Compare RDY & RKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • RKT
  • Stock Information
  • Founded
  • RDY 1984
  • RKT 1985
  • Country
  • RDY India
  • RKT United States
  • Employees
  • RDY N/A
  • RKT N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • RKT Finance: Consumer Services
  • Sector
  • RDY Health Care
  • RKT Finance
  • Exchange
  • RDY Nasdaq
  • RKT Nasdaq
  • Market Cap
  • RDY 2.1B
  • RKT 1.9B
  • IPO Year
  • RDY N/A
  • RKT 2020
  • Fundamental
  • Price
  • RDY $13.24
  • RKT $13.84
  • Analyst Decision
  • RDY Buy
  • RKT Hold
  • Analyst Count
  • RDY 1
  • RKT 12
  • Target Price
  • RDY $17.00
  • RKT $13.92
  • AVG Volume (30 Days)
  • RDY 1.9M
  • RKT 13.0M
  • Earning Date
  • RDY 05-06-2025
  • RKT 05-01-2025
  • Dividend Yield
  • RDY 3.61%
  • RKT 5.78%
  • EPS Growth
  • RDY 2.68
  • RKT N/A
  • EPS
  • RDY 0.75
  • RKT 0.21
  • Revenue
  • RDY $3,637,607,642.00
  • RKT $5,416,391,000.00
  • Revenue This Year
  • RDY $17.23
  • RKT $10.07
  • Revenue Next Year
  • RDY $9.19
  • RKT $19.44
  • P/E Ratio
  • RDY $17.94
  • RKT $66.51
  • Revenue Growth
  • RDY 14.74
  • RKT 35.21
  • 52 Week Low
  • RDY $12.50
  • RKT $10.06
  • 52 Week High
  • RDY $16.89
  • RKT $21.38
  • Technical
  • Relative Strength Index (RSI)
  • RDY 48.34
  • RKT 51.78
  • Support Level
  • RDY $13.09
  • RKT $11.60
  • Resistance Level
  • RDY $13.85
  • RKT $13.53
  • Average True Range (ATR)
  • RDY 0.14
  • RKT 0.79
  • MACD
  • RDY 0.02
  • RKT -0.13
  • Stochastic Oscillator
  • RDY 19.74
  • RKT 52.71

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About RKT Rocket Companies Inc.

Rocket Companies is a financial services company that was originally founded as Rock Financial in 1985 and is currently based in Detroit. Rocket Companies offers a wide array of services and products but is best known for its Rocket Mortgage business. The company's mortgage lending operations are split between its direct-to-consumer lending, which sees borrowers accessing the company's lending arm directly through either its mobile app or website, and its partner network where mortgage brokers and other firms use Rocket's origination process to offer loans to their customers. The company has rapidly gained market share in recent years and is now the largest mortgage originator in the U.S. as well as the servicer for more than 2 million loans.

Share on Social Networks: